Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate Ductal Adenocarcinoma.

Ali Amin1

  • 1Pathology, Brown University, Providence, RI.

Applied Immunohistochemistry & Molecular Morphology : AIMM
|April 1, 2017
PubMed
Summary

Prostate ductal adenocarcinoma (PDA) is a rare, aggressive cancer. Histopathology is crucial for diagnosing PDA, distinguishing it from other prostate cancers, and determining patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urothelial Carcinoma in Children and Young Adults is Characterized by Higher Frequency of HRAS Mutations and Lower Prevalence of TERT Promoter and FGFR3 Mutations.

The American journal of surgical pathology·2026
Same author

Active surveillance for prostate cancer: current status and future directions.

Current opinion in urology·2026
Same author

Protein-Protein Interactions in Papillary and Nonpapillary Urothelial Carcinoma Architectures: Comparative Study.

JMIR bioinformatics and biotechnology·2025
Same author

The GNAS Gene: Fibrous Dysplasia, McCune-Albright Syndrome, and Skeletal Structure and Function.

Genes·2025
Same author

Pathologist-like explainable AI for interpretable Gleason grading in prostate cancer.

Nature communications·2025
Same author

Genetic profiling of upper tract urothelial carcinoma: A necessity for precision medicine.

Expert review of molecular diagnostics·2025

Area of Science:

  • Uropathology
  • Oncology
  • Surgical Pathology

Background:

  • Prostate ductal adenocarcinoma (PDA) is a rare subtype of prostate adenocarcinoma.
  • PDA exhibits more aggressive behavior compared to conventional prostatic acinar adenocarcinoma.
  • Clinical distinction between PDA and prostatic acinar adenocarcinoma is challenging due to similar presentations.

Purpose of the Study:

  • To provide a comprehensive review of diagnostic and prognostic information for PDA.
  • To detail morphologic features, variants, and grading of PDA.
  • To discuss differential diagnosis, immunohistochemistry utility, and prognostic pathological features.

Main Methods:

  • Literature review focusing on histopathology, immunohistochemistry, and prognostic factors of PDA.
  • Analysis of morphologic characteristics and variants of PDA.
  • Comparison with common morphologic mimickers and conventional prostatic acinar adenocarcinoma.

Main Results:

  • Histopathology is essential for accurate PDA diagnosis.
  • Immunohistochemistry aids in differentiating PDA from mimickers.
  • Specific pathological features are identified to predict patient outcomes.

Conclusions:

  • Accurate diagnosis of PDA relies heavily on histopathological evaluation.
  • Understanding PDA variants and utilizing immunohistochemistry improves diagnostic accuracy.
  • Identification of prognostic pathological features is key for patient management and outcome prediction.

Related Experiment Videos